home / stock / akao / akao quote
$ Last:
Change Percent:
$ Open:
$ Previous Close:
$ High:
$ Low:
0 Volume:
01/01/1970 12:00:00 am Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Stock Date | Open Price | Close Price | High | Low | Volume |
---|---|---|---|---|---|
2019-04-25 | 0.106 | 0.11 | 0.19 | 0.102 | 47,627,225 |
2019-04-24 | 0.118 | 0.1076 | 0.13 | 0.1034 | 9,541,741 |
2019-04-23 | 0.1593 | 0.1372 | 0.1596 | 0.13 | 3,999,234 |
2019-04-22 | 0.175 | 0.1521 | 0.175 | 0.151 | 4,770,823 |
2019-04-19 | 0.1775 | 0.1748 | 0.179 | 0.163 | 2,846,546 |
2019-04-18 | 0.1775 | 0.1748 | 0.179 | 0.163 | 2,782,220 |
2019-04-17 | 0.178 | 0.184 | 0.195 | 0.1721 | 7,429,554 |
2019-04-16 | 0.16 | 0.1627 | 0.22 | 0.159 | 26,542,390 |
2019-04-15 | 0.2216 | 0.1557 | 0.33 | 0.145 | 34,663,959 |
2019-04-12 | 0.46 | 0.495 | 0.5198 | 0.46 | 1,100,135 |
2019-04-11 | 0.5072 | 0.486 | 0.53 | 0.48 | 489,077 |
2019-04-10 | 0.5061 | 0.5072 | 0.54 | 0.489 | 1,617,166 |
2019-04-09 | 0.48 | 0.516 | 0.535 | 0.48 | 1,323,422 |
2019-04-08 | 0.545 | 0.52 | 0.545 | 0.5011 | 1,403,821 |
2019-04-05 | 0.55 | 0.5381 | 0.569 | 0.5175 | 1,849,080 |
2019-04-04 | 0.5188 | 0.52 | 0.5999 | 0.49 | 4,172,340 |
2019-04-03 | 0.43 | 0.4796 | 0.50 | 0.4201 | 2,120,259 |
2019-04-02 | 0.4369 | 0.4338 | 0.4435 | 0.415 | 1,839,548 |
2019-04-01 | 0.4682 | 0.4369 | 0.47 | 0.4201 | 1,173,159 |
2019-03-29 | 0.41 | 0.4563 | 0.4849 | 0.40 | 2,293,986 |
News, Short Squeeze, Breakout and More Instantly...
SOUTH SAN FRANCISCO, Calif., June 06, 2019 (GLOBE NEWSWIRE) -- Achaogen, Inc., a biopharmaceutical company developing and commercializing innovative antibacterial agents to address multi-drug resistant (MDR) gram-negative infections, announced today it has reached agreements to sell substan...
SOUTH SAN FRANCISCO, Calif., April 15, 2019 (GLOBE NEWSWIRE) -- Achaogen, Inc. (Nasdaq: AKAO), a biopharmaceutical company developing and commercializing innovative antibacterial agents to address multi-drug resistant (MDR) gram-negative infections, announced today that it has filed a volun...
-- ZEMDRI’s once-daily 30-minute infusion facilitating usage in the outpatient setting -- -- Company’s recent restructuring aimed at conserving capital to continue assessment of strategic alternatives -- -- Conference call today at 4:30 p.m. Eastern Time -- SOUTH S...